S. Kudoh

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

N Masuda, M. Fukuoka, Y Kusunoki et al. · Journal of Clinical Oncology · 1992 · 448 citations

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Japanese patients with solid malignant tumors

Kazuhiko Nakagawa, Tomohiro Tamura, Shunichi Negoro et al. · Annals of Oncology · 2003 · 274 citations · Full text

Japanese Patients, Oncology, Malignant Disease +8

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

S. Negoro, M. Fukuoka, N Masuda et al. · JNCI Journal of the National Cancer Institute · 1991 · 274 citations

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

Hiroaki Okamoto, Kenji Watanabe, Hiroshi Kunikane et al. · British Journal of Cancer · 2007 · 210 citations · Full text

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer

N Masuda, M. Fukuoka, S. Kudoh et al. · British Journal of Cancer · 1993 · 94 citations · Full text

Advanced Lung Cancer, Oncology, Medicine +8